Abbott gets restraining order against ex-VP in COVID-19 trade secrets dispute

Biopharmaceutical company, Abbott Laboratories, has successfully obtained a restraining order against its former vice-president of global marketing, whom it has accused of stealing trade secrets relating to COVID-19 products.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Oakwood convinces third circuit to reopen TS suit

10 June 2021 Oakwood Laboratories has convinced third circuit judges to revive a trade secrets dispute with its former vice president of product developments over microsphere drugs.

Medtech

Senator calls on Biden to reject COVID IP waiver

2 March 2021 Thom Tillis, ranking member of the senate IP subcommittee, has urged US president Joe Biden to oppose ‘harmful’ proposals to waive rights related to COVID-19 vaccines currently in discussions at the World Trade Organisation.

Americas

Abbott must face HIV testing patent suit, rules judge

4 December 2020 Abbott Laboratories must face allegations brought by Grifols Diagnostic and a Novartis subsidiary that its HIV testing products infringe a patent covering a method to create HIV proteins using recombinant DNA.

More on this story

Big Pharma

Oakwood convinces third circuit to reopen TS suit

10 June 2021 Oakwood Laboratories has convinced third circuit judges to revive a trade secrets dispute with its former vice president of product developments over microsphere drugs.

Medtech

Senator calls on Biden to reject COVID IP waiver

Americas

Abbott must face HIV testing patent suit, rules judge

More on this story

Big Pharma

Oakwood convinces third circuit to reopen TS suit

10 June 2021 Oakwood Laboratories has convinced third circuit judges to revive a trade secrets dispute with its former vice president of product developments over microsphere drugs.

Medtech

Senator calls on Biden to reject COVID IP waiver

Americas

Abbott must face HIV testing patent suit, rules judge